GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Price-to-Operating-Cash-Flow

Advanced Oncotherapy (LSE:AVO) Price-to-Operating-Cash-Flow : (As of May. 16, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Price-to-Operating-Cash-Flow?

As of today (2024-05-16), Advanced Oncotherapy's share price is £0.01925. Advanced Oncotherapy's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was £-0.06. Hence, Advanced Oncotherapy's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Advanced Oncotherapy's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:AVO's Price-to-Operating-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 21.9
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Advanced Oncotherapy's Cash Flow from Operations per share for the six months ended in Jun. 2022 was £-0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was £-0.06.


Advanced Oncotherapy Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Advanced Oncotherapy's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Price-to-Operating-Cash-Flow Chart

Advanced Oncotherapy Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Advanced Oncotherapy Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Advanced Oncotherapy's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Advanced Oncotherapy's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Oncotherapy's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Oncotherapy's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Advanced Oncotherapy's Price-to-Operating-Cash-Flow falls into.



Advanced Oncotherapy Price-to-Operating-Cash-Flow Calculation

Advanced Oncotherapy's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.01925/-0.058
=

Advanced Oncotherapy's Share Price of today is £0.01925.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Oncotherapy's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was £-0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Advanced Oncotherapy Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Oncotherapy (LSE:AVO) Business Description

Traded in Other Exchanges
N/A
Address
4 Tenterden Street, Third Floor, London, GBR, W1S 1TE
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.